Vitamin D deficiency in HIV-infected individuals: One more risk factor for bone loss and cardiovascular disease?;Deficiência de vitamina D em indivíduos infectados pelo HIV: Mais um fator de risco para perda óssea e doença cardiovascular?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 2, 2010, Pages 118-122

  Conrado, Tereza ^a   Miranda Filho, Demócrito de Barros ^a   Bandeira, Francisco ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

ART; HIV; Vitamin D; Vitamin D deficiency

Indexed keywords

EID: 77952721533     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000200006     Document Type: Article

References (29)

1. UNAIDS. Aids Epidemic Update 2008. Available from: http:// www.unaids.org. htm (Access May 15, 2009).
2. Ministério DA Saúde. Boletim Epidemiológico - Aids e DST, Janeiro a Junho de 2008, Ano V, n°. 1, p. 1-36. Brasília, Dezembro, 2008. Available from: http:// www.aids.gov.br. htm (Access May 15, 2009).
3. Dourado I, Veras MAS, Barreira D, Brito AM. Tendências da epidemia de Aids no Brasil após a terapia antirretroviral. Rev Saude Publica. 2006;40(S):9-17.
4. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS. 2003;1:(S)141-48.
5. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JE, Dubé MP, et al. State of the Science Conference Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS. Circulation. 2008;118(2):198-210.
6. DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356(17):1723-35.
7. Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging. 2004;48:39-48.
8. Yin M, Dobkin J, Brudney K, Becker C, Zadel JL, Manandhar M. Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporosis Int. 2005;16:1345-52.
9. Pernerstorfer-Schoen H, Jilma B, Perschler A, Wichlas S, Schindler K, Schindl A, et al. Sex differences in HAART-associated dyslipidaemia. AIDS. 2001;15:725-34.
10. Ministério da Saúde. Secretaria de Vigilância em Saúde, Programa Nacional de DST e Aids. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV 2008. Documento preliminar 2007. Available from: www.saude.rio.rj.gov.br/media/dstaids_consenso_adulto_2008.pdf
11. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev. 2006;64:226-33.
12. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldrovandi GM, Wilson CM. Vitamin D status in adolescentes and young adults with HIV infection. Am J Clin Nutr. 2006;83:1135-41.
13. Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Froland SS. Deficiency 1,25 didroxi vitamin D3 in human immunodeficiency hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998;83:3832-8.
14. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-73.
15. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
16. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV protease inhibitor impairs vitamin D bioactivation 1,25-dihydroxyvitamin D. AIDS. 2003;17:513-20.
17. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Benjamin EJ, Ingelsson E, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-11.
18. Melamed ML, Michos ED, Post W, Brad A. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-37.
19. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men. A prospective study. Arch Intern Med. 2008;168:1174-80.
20. Kremer R, Campbell PP, Reinhard T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009;94:67-73.
21. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89:1321-7.
22. Bandeira F, Griz L, Dreyer P, Bandeira C, Eufrazino C, Freese E. Vitamin D Deficiency: a global perspective. Arq Bras Endocrinol Metab. 2006;50:640-5.
23. Bandeira F, Griz L, Freese E, Lima DC, Thé AC, Diniz ET, et al. Vitamin D deficiency and its relationship with bone mineral density among postmenopausal women living in the tropics. Arq Bras Endocrinol Metab. 2010;54(2):227-32.
24. Seminari E, Samaras K, Wand H, Law M, Emery S, Cooper D, et al. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. HIV Med. 2005;6:145-50.
25. Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24:1375-82.
26. Aparicio AMG, Fernández SM, González J, Arribas JR, Peña JM, Vázquez JJ, et al. Abnormalities in the bone mineral metabolism in HIV-infected patients. Clin Rheumatol. 2006;25:537-9.
27. Rodríguez M, Daniel SB, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses. 2009;25:9-14.
28. Ford ES, Ajani UA, Mcguire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28:1228-30.
29. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance. The Medical Research Council Ely Prospective Study 1990-2000. Available from: http://diabetes.diabetesjournals.org. Access June 30, 2008